Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Biogen Idec building

Biogen completes haemophilia business separation

Spin-out Bioverativ launched to focus exclusively on rare blood disorders

- PMLiVE

Heart research campaign urges chocolate detox for workers

British Heart Foundation hopes to inspire officer workers to abstain in March

AstraZeneca AZ

2017 set to be a “defining year” for AZ

Potential immuno-oncology blockbuster durvalumab leads the charge for AZ’s new launches

CureVac’s CEO appointed to EC High Level Group

Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes

Roche Basel Switzerland

Tecentriq growth offsets Avastin’s US decline at Roche

Shifts focus to newer therapies in anticipation of brewing biosimilar competition

- PMLiVE

Mining for results

How one tech firm is working with Big Data

- PMLiVE

Akinion’s Dr Richard Jones joins Holostem Terapie Avanzate

He takes on the role of chief executive officer

Is fear an effective driver of behaviour change?

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.

Blue Latitude Health

- PMLiVE

PharmaLex Group strengthens development consulting team

Carolyn Belcher and Lutz Wevelsiep join the German pharma services provider

- PMLiVE

Promimic appoints CEO

Magnus Larsson succeeds Ulf Brogren at the Swedish firm

- PMLiVE

Trump talks pricing and manufacturing with pharma

Heads of Celgene, Lilly, Merck & Co, Novartis and trade body PhRMA met at the White House

Sanofi reception

Sanofi/Regeneron bag first approval for Actemra rival sarilumab

Competition to Roche’s blockbuster RA therapy heats up as Canada is first to licence new drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links